What about tocilizumab? A retrospective study from a NYC Hospital during the COVID-19 outbreak.

What about tocilizumab? A retrospective study from a NYC Hospital during the COVID-19 outbreak.

<h4>Background</h4>Tocilizumab, an interleukin-6 receptor blocker, has been used in the inflammatory phase of COVID-19, but its impact independent of corticosteroids remains unclear in patients with severe disease.<h4>Methods</h4>In this retrospective analysis of patients wit...

Full description

Bibliographic Details
Main Authors: Monica Mehta, Lawrence J Purpura, Thomas H McConville, Matthew J Neidell, Michaela R Anderson, Elana J Bernstein, Donald E Dietz, Justin Laracy, Shauna H Gunaratne, Emily Happy Miller, Jennifer Cheng, Jason Zucker, Shivang S Shah, Shaoli Chaudhuri, Christian A Gordillo, Shreena R Patel, Tai Wei Guo, Lara E Karaaslan, Ran Reshef, Benjamin A Miko, Joan M Bathon, Marcus R Pereira, Anne-Catrin Uhlemann, Michael T Yin, Magdalena E Sobieszczyk
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0249349

Internet

https://doi.org/10.1371/journal.pone.0249349

Similar Items